(Q38851217)

7 September 2017

1 reference

title

Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines (English)

1 reference

7 September 2017

main subject

foot-and-mouth disease

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Cyril Gay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

L Robinson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

T J D Knight-Jones

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

L L Rodriguez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

K J Sumption

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

W Vosloo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

1 reference

1 June 2016

1 reference

Transboundary and Emerging Diseases

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

63 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

30-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Developments in foot-and-mouth disease vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Positively charged residues at the five-fold symmetry axis of cell culture-adapted foot-and-mouth disease virus permit novel receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

B epitope multiplicity and B/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Accuracy of traditional and novel serology tests for predicting cross-protection in foot-and-mouth disease vaccinated cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Adjuvants for foot-and-mouth disease virus vaccines: recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Identification of a novel cell culture adaptation site on the capsid of foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Adjuvant effect enhancement of porcine interleukin-2 packaged into solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Enhancement of the immune responses to foot-and-mouth disease vaccination in mice by oral administration of a novel polysaccharide from the roots of Radix Cyathulae officinalis Kuan (RC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Novel polysaccharide from Radix Cyathulae officinalis Kuan can improve immune response to ovalbumin in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Assembly and characterization of foot-and-mouth disease virus empty capsid particles expressed within mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

CpG ODN nanorings induce IFNα from plasmacytoid dendritic cells and demonstrate potent vaccine adjuvant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Proper quality control of formulated foot-and-mouth disease vaccines in countries with prophylactic vaccination is necessary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Targeted Delivery of VP1 Antigen of Foot-and-mouth Disease Virus to M Cells Enhances the Antigen-specific Systemic and Mucosal Immune Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Veterinary and human vaccine evaluation methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Serological responses after vaccination of growing pigs with foot-and-mouth disease trivalent (type O, A and Asia1) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Presentation of epitope sequences from foreign viruses on the surface of apple latent spherical virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Identification of cytotoxic T lymphocyte epitopes on swine viruses: multi-epitope design for universal T cell vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Antigenic variation of foot-and-mouth disease virus serotype A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Epidemiological analysis of an outbreak of foot-and-mouth disease (serotype SAT2) on a large dairy farm in Kenya using regular vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Analysis of SAT type foot-and-mouth disease virus capsid proteins and the identification of putative amino acid residues affecting virus stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

A proposal for an alternative quality control test procedure for inactivated vaccines against food-and-mouth disease virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1-OmpA in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Elimination of foot-and-mouth disease in South America: lessons and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Vaccination against foot-and-mouth disease virus: strategies and effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Low levels of foot-and-mouth disease virus 3C protease expression are required to achieve optimal capsid protein expression and processing in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Evolutionary non-linear modelling for selecting vaccines against antigenically variable viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Reducing animal experimentation in foot-and-mouth disease vaccine potency tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Development of vaccines toward the global control and eradication of foot-and-mouth disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Evaluation of laboratory tests for SAT serotypes of foot-and-mouth disease virus with specimens collected from convalescent cattle in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Characterization of epitope-tagged foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Control and eradication of foot-and-mouth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

A plate-based high-throughput assay for virus stability and vaccine formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Size-exclusion HPLC provides a simple, rapid, and versatile alternative method for quality control of vaccines by characterizing the assembly of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Rapeseed oil and ginseng saponins work synergistically to enhance Th1 and Th2 immune responses induced by the foot-and-mouth disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Resiquimod and polyinosinic-polycytidylic acid formulation with aluminum hydroxide as an adjuvant for foot-and-mouth disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FTBED.12521

21 January 2018

Identifiers

DOI

10.1111/TBED.12521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27320164%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference